A small-cap merger arbitrage opportunity with double-digit upside potential (from Special Situation Investments)…

Neighbourly Pharmacy (NBLY) – Merger Arbitrage – 16% Upside This is an intriguing non-binding stage merger arbitrage opportunity in Canada. While the market is skeptical about transaction closing, I think there is a solid chance that the situation will successfully play out in the coming weeks or months. NBLY is a C$700m market cap Canadian

Activist short seller Culper Research alleges fraud in a Chinese medical-supply firm (from Culper via X)…

1) We are short Jin Medical International Ltd $ZJYL, a China Hustle-style charade. Jin sells wheelchairs and parts in China. In 2022, its revenues fell 8% to just $19M. $ZJYL trades at ~45x revenues. At reasonable “peer” levels of 1-6x sales, $ZJYL shares fall 90% or more. 2) $ZJYL went public in March 2023, underwritten

With the imminent rescheduling of cannabis from from a Schedule III to Schedule I drug, insiders have perked up in the stocks (from Kuppy’s Event Driven Monitor)…

We saw Jason Wild of [Terrascend (TSND.CN)] gobbling up stock all of 2023. This [month] we note insiders bought at Tilray Brands (TLRY). Granted it’s not a pure play cannabis company anymore (they bought a craft beer basket from BUD in 2023, e.g. ShockTop, RedHook, etc), but the CFO’s spouse bought ~$37K worth, the CEO

Two overlooked “spinoff” stocks that could be ready to soar (from Forbes)…

I speak a lot about hidden values in spinoffs, but this is a great place to hunt for value that a few key investors investigate. Spinoffs are sometimes called ‘orphan securities.’ The definition pertains to a stock or other financial instrument that industry analysts do not routinely monitor or cover. As a result, these securities

A summary of two special situation investment opportunities with near-term catalysts (from Idea Hive)…

Ocean Wilson (OCN:L, £350m) Ocean Wilson is an investment company with two key holdings: OWIL, a fund of funds, and a 57% stake in publicly-listed Wilson Sons, one of the largest providers of maritime services in Brazil. OCN is currently trading at a 50%+ discount to NAV. However, unlike in a regular [sum of the

This upcoming spinoff could unlock significant value for shareholders (from ToffCap)…

I’m looking with much interest into the upcoming Solvay split. On December 11, Solvay will split its business in a commoditized chemicals part (maintaining the name Solvay) and a ‘specialty’ chemicals part (to be called Syensqo). I believe the split could unlock significant value as the market seems to greatly underestimate the current SOTP value.